107 related articles for article (PubMed ID: 28103788)
1. Pharmacokinetics, Metabolism and Disposition of [14C]XQ-1H After Intravenous Administration to Male Rats.
Qin Y; Chen T; Jin Q; Guo K; Feng H; Heller D; Gu ZM
Drug Metab Lett; 2017; 10(4):228-239. PubMed ID: 28103788
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Blood-Brain Barrier Dysfunction by XQ-1H Following Ischemic Stroke in Hyperlipidemic Rats.
Fang W; Sha L; Kodithuwakku ND; Wei J; Zhang R; Han D; Mao L; Li Y
Mol Neurobiol; 2015 Aug; 52(1):162-75. PubMed ID: 25128027
[TBL] [Abstract][Full Text] [Related]
3. XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/β-catenin signaling dependent way.
Xu D; Hou K; Li F; Chen S; Fang W; Li Y
Life Sci; 2019 Oct; 235():116844. PubMed ID: 31499069
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics analysis of XQ-1H and its combination therapy with clopidogrel on cerebral ischemic reperfusion injury in rats.
Khadankhuu B; Fei Y; Xu D; Li Y; Hou K; Li F; Fang W; Chen X; Li Y
J Pharm Biomed Anal; 2020 Feb; 179():112975. PubMed ID: 31735472
[TBL] [Abstract][Full Text] [Related]
5. Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats.
Yang ZZ; Li J; Li SX; Feng W; Wang H
J Ethnopharmacol; 2011 Jun; 136(1):117-22. PubMed ID: 21527331
[TBL] [Abstract][Full Text] [Related]
6. XQ-1H promotes cerebral angiogenesis via activating PI3K/Akt/GSK3β/β-catenin/VEGF signal in mice exposed to cerebral ischemic injury.
Fei Y; Zhao B; Zhu J; Fang W; Li Y
Life Sci; 2021 May; 272():119234. PubMed ID: 33607158
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia.
Yang Q; Fang W; Lv P; Geng X; Li Y; Sha L
Pharmacology; 2012; 89(1-2):1-6. PubMed ID: 22178991
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, tissue distribution, excretion, and metabolism of a new cardioprotective agent 10-O-dimethylaminoethylginkgolide B in rats.
Wang DL; Peng DY; Liu XD; Zhang X; Chen WD; Liang Y; Wang XT; Xie T; Xie L; Wang GJ
J Asian Nat Prod Res; 2012; 14(1):27-38. PubMed ID: 22263591
[TBL] [Abstract][Full Text] [Related]
9. XQ-1H attenuates ischemic injury in PC12 cells via Wnt/β-catenin signaling though inhibition of apoptosis and promotion of proliferation.
Xu D; Li F; Hou K; Gou X; Fang W; Li Y
Cell Biol Int; 2020 Nov; 44(11):2363-2369. PubMed ID: 32761926
[TBL] [Abstract][Full Text] [Related]
10. XQ-1H protects against ischemic stroke by regulating microglia polarization through PPARγ pathway in mice.
Liu R; Diao J; He S; Li B; Fei Y; Li Y; Fang W
Int Immunopharmacol; 2018 Apr; 57():72-81. PubMed ID: 29475098
[TBL] [Abstract][Full Text] [Related]
11. XQ-1H regulates Wnt/GSK3β/β-catenin pathway and ameliorates the integrity of blood brain barrier in mice with acute ischemic stroke.
Fei YX; Zhu JP; Zhao B; Yin QY; Fang WR; Li YM
Brain Res Bull; 2020 Nov; 164():269-288. PubMed ID: 32916221
[TBL] [Abstract][Full Text] [Related]
12. Isolation and structure characterization of related impurities in 10-O-(N,N-dimethylaminoethyl)-ginkgolide B methanesulfonate (XQ-1H) bulk drug and quantitation by a validated RP-LC.
Liu W; Li P; Feng F; Mao L
J Pharm Biomed Anal; 2010 Aug; 52(4):603-8. PubMed ID: 20138458
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.
Wang S; Ouyang B; Aa J; Geng J; Fei F; Wang P; Wang J; Peng Y; Geng T; Li Y; Huang W; Wang Z; Xiao W; Wang G
J Pharm Biomed Anal; 2016 Jul; 126():109-16. PubMed ID: 27182682
[TBL] [Abstract][Full Text] [Related]
14. Transformation of multi-component ginkgolide into ginkgolide B by Coprinus comatus.
Ding H; Zhang Z; Cao S; Xu Y; Yu J
BMC Biotechnol; 2015 Mar; 15():17. PubMed ID: 25887229
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats.
Chen WD; Liang Y; Xie L; Lu T; Liu XD; Wang GJ
Biol Pharm Bull; 2007 Jan; 30(1):1-5. PubMed ID: 17202649
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma.
Wang DL; Peng DY; Tao XH; Cao Y; Chen WD; Liang Y; Xie L; Liu XD
J Asian Nat Prod Res; 2013; 15(4):337-43. PubMed ID: 23421864
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic time window for treatment of focal cerebral ischemia reperfusion injury with XQ-1h in rats.
Sun J; Li Y; Fang W; Mao L
Eur J Pharmacol; 2011 Sep; 666(1-3):105-10. PubMed ID: 21645512
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective effect of extract of Ginkgo biloba against excitotoxicty compared with ginkgolide B in neuron cell of rat].
Xu J; Sun C; Ma H; Wang L; Zhang J; Zhang Y; Wu L
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(1):114-7. PubMed ID: 20349729
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects.
Deng Y; Fang W; Li Y; Cen J; Fang F; Lv P; Gong S; Mao L
Eur J Pharmacol; 2009 Aug; 616(1-3):43-7. PubMed ID: 19555682
[TBL] [Abstract][Full Text] [Related]
20. Different neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia.
Huang M; Qian Y; Guan T; Huang L; Tang X; Li Y
Eur J Pharmacol; 2012 Feb; 677(1-3):71-6. PubMed ID: 22197649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
